Ausgabe 1/2023
Inhalt (153 Artikel)
PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies
Saisai Chen, Matt R. Paul, Christopher J. Sterner, George K. Belka, Dezhen Wang, Peining Xu, Amulya Sreekumar, Tien-chi Pan, Dhruv K. Pant, Igor Makhlin, Angela DeMichele, Clementina Mesaros, Lewis A. Chodosh
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Sanne L. de Haas, Dennis J. Slamon, Miguel Martin, Michael F. Press, Gail D. Lewis, Chiara Lambertini, Aleix Prat, Vanesa Lopez-Valverde, Thomas Boulet, Sara A. Hurvitz
MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer
Zhiwen Cao, Rui Liu, Yang Li, Xinyi Luo, Zhenglai Hua, Xiangpeng Wang, Zeyu Xue, Zhengjia Zhang, Cheng Lu, Aiping Lu, Yuanyan Liu
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
Chang Gon Kim, Min Hwan Kim, Jee Hung Kim, Seul-Gi Kim, Gun Min Kim, Tae Yeong Kim, Won-Ji Ryu, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joon Jeong, Joohyuk Sohn
A prospective case–cohort analysis of plasma metabolites and breast cancer risk
Victoria L. Stevens, Brian D. Carter, Eric J. Jacobs, Marjorie L. McCullough, Lauren R. Teras, Ying Wang
Sustained postconfluent culture of human mammary epithelial cells enriches for luminal and c-Kit+ subtypes
Michael E. Todhunter, Masaru Miyano, Eric G. Carlson, Stefan Hinz, Mark A. LaBarge
Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study
Oluwatosin A. Ayeni, Maureen Joffe, Witness Mapanga, Wenlong Carl Chen, Daniel S. O’Neil, Boitumelo Phakathi, Sarah Nietz, Ines Buccimazza, Sharon Čačala, Laura W. Stopforth, Judith S. Jacobson, Katherine D. Crew, Alfred I. Neugut, Duvern Ramiah, Paul Ruff, Herbert Cubasch, Tobias Chirwa, Valerie McCormack, Lisa K. Micklesfield, Shane A. Norris
A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old
Mara A. Schonberg, Emily A. Wolfson, A. Heather Eliassen, Kimberly A. Bertrand, Yurii B. Shvetsov, Bernard A. Rosner, Julie R. Palmer, Long H. Ngo
Association between human blood metabolome and the risk of breast cancer
Yu Wang, Fanghua Liu, Lulu Sun, Yiming Jia, Pinni Yang, Daoxia Guo, Mengyao Shi, Aili Wang, Guo-Chong Chen, Yonghong Zhang, Zhengbao Zhu
Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity
Zhaoshan Liu, Swati Choksi, Hyung-Joon Kwon, Delong Jiao, Chengyu Liu, Zheng-gang Liu
Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
Huang-Chun Lien, Chia-Lang Hsu, Yen-Shen Lu, Tom Wei-Wu Chen, I.-Chun Chen, Yu-Chia Li, Chiun-Sheng Huang, Ann-Lii Cheng, Ching-Hung Lin
Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy
Mikhail V. Pavlov, Anna P. Bavrina, Vladimir I. Plekhanov, German Yu. Golubyatnikov, Anna G. Orlova, Pavel V. Subochev, Diana A. Davydova, Ilya V. Turchin, Anna V. Maslennikova
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi, Naoki Niikura
Correction: Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study
Oluwatosin A. Ayeni, Maureen Jofe, Witness Mapanga, Wenlong Carl Chen, Daniel S. O’Neil, Boitumelo Phakathi, Sarah Nietz, Ines Buccimazza, Sharon Čačala, Laura W. Stopforth, Judith S. Jacobson, Katherine D. Crew, Alfred I. Neugut, Duvern Ramiah, Paul Ruf, Herbert Cubasch, Tobias Chirwa, Valerie McCormack, Lisa K. Micklesfeld, Shane A. Norris
Correction: A prospective case–cohort analysis of plasma metabolites and breast cancer risk
Victoria L. Stevens, Brian D. Carter, Eric J. Jacobs, Marjorie L. McCullough, Lauren R. Teras, Ying Wang
Correction: Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy
Mikhail V. Pavlov, Anna P. Bavrina, Vladimir I. Plekhanov, German Yu. Golubyatnikov, Anna G. Orlova, Pavel V. Subochev, Diana A. Davydova, Ilya V. Turchin, Anna V. Maslennikova
Evaluation and comparison of different breast cancer prognosis scores based on gene expression data
Avirup Chowdhury, Paul D. Pharoah, Oscar M. Rueda
Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
Isaac Allen, Hend Hassan, Eleni Sofianopoulou, Diana Eccles, Clare Turnbull, Marc Tischkowitz, Paul Pharoah, Antonis C. Antoniou
METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer
Dengjie Ouyang, Tao Hong, Mengdie Fu, Yitong Li, Liyun Zeng, Qitong Chen, Hongye He, Ying Wen, Yan Cheng, Meirong Zhou, Qiongyan Zou, Wenjun Yi
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial
Eun-Shin Lee, Yumi Kim, Hee-Chul Shin, Ki-Tae Hwang, Junwon Min, Min Kyoon Kim, SooKyung Ahn, So-Youn Jung, Hyukjai Shin, MinSung Chung, Tae-Kyung Yoo, Seungpil Jung, Sang Uk Woo, Ju-Yeon Kim, Dong-Young Noh, Hyeong-Gon Moon
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
Sumito Saeki, Kohei Kumegawa, Yoko Takahashi, Liying Yang, Tomo Osako, Mahmut Yasen, Kazutaka Otsuji, Kenichi Miyata, Kaoru Yamakawa, Jun Suzuka, Yuri Sakimoto, Yukinori Ozaki, Toshimi Takano, Takeshi Sano, Tetsuo Noda, Shinji Ohno, Ryoji Yao, Takayuki Ueno, Reo Maruyama
CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
Zhao-Hui Chen, Yao Tian, Guang-Lei Zhou, Hao-Ran Yue, Xue-Jie Zhou, Hai-Yan Ma, Jie Ge, Xin Wang, Xu-Chen Cao, Yue Yu
Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits
Gadisti Aisha Mohamed, Sundis Mahmood, Nevena B. Ognjenovic, Min Kyung Lee, Owen M. Wilkins, Brock C. Christensen, Kristen E. Muller, Diwakar R. Pattabiraman
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
Cassandra A. Hathaway, Megan S. Rice, Laura C. Collins, Dilys Chen, David A. Frank, Sarah Walker, Charles V. Clevenger, Rulla M. Tamimi, Shelley S. Tworoger, Susan E. Hankinson
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
Sanjib Chaudhary, Muthamil Iniyan Appadurai, Shailendra Kumar Maurya, Palanisamy Nallasamy, Saravanakumar Marimuthu, Ashu Shah, Pranita Atri, Chirravuri Venkata Ramakanth, Subodh M. Lele, Parthasarathy Seshacharyulu, Moorthy P. Ponnusamy, Mohd W. Nasser, Apar Kishor Ganti, Surinder K. Batra, Imayavaramban Lakshmanan
RET signaling in breast cancer therapeutic resistance and metastasis
Geoffrey Pecar, Simeng Liu, Jagmohan Hooda, Jennifer M. Atkinson, Steffi Oesterreich, Adrian V. Lee
A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
Gurcan Tunali, Hamdullah Yanik, Suleyman Can Ozturk, Secil Demirkol-Canli, Georgios Efthymiou, Kerim Bora Yilmaz, Ellen Van Obberghen-Schilling, Gunes Esendagli
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi, Naoki Niikura
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
Frida Björk Gunnarsdottir, Pär-Ola Bendahl, Alexandra Johansson, Rui Benfeitas, Lisa Rydén, Caroline Bergenfelz, Anna-Maria Larsson
Impact of breast cancer care pathways and related symptoms on the return-to-work process: results from a population-based French cohort study (CONSTANCES)
Anne-Lise Rolland, Bertrand Porro, Sofiane Kab, Céline Ribet, Yves Roquelaure, Mélanie Bertin
The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
Wei Wang, Priyanka S. Rana, Vesna Markovic, Khalid Sossey-Alaoui
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy
Pauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, Theresa Link, Marianne Just, Bruno Valentin Sinn, Eike Simon, Christine Solbach, Tanja Fehm, Carsten Denkert, Cristin Kühn, Kerstin Rhiem, Hans Tesch, Sherko Kümmel, Andrea Petzold, Oliver Stötzer, Cornelia Meisel, Jan Dominik Kuhlmann, Valentina Nekljudova, Sibylle Loibl
Associations of alcohol consumption with breast tissue composition
Lusine Yaghjyan, Yujing J. Heng, Gabrielle M. Baker, Bernard A. Rosner, Rulla M. Tamimi
Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
Xi′e Hu, Ping Yang, Songhao Chen, Gang Wei, Lijuan Yuan, Zhenyu Yang, Li Gong, Li He, Lin Yang, Shujia Peng, Yanming Dong, Xianli He, Guoqiang Bao
Lifetime changes in body fatness and breast density in postmenopausal women: the FEDRA study
Giovanna Masala, Benedetta Bendinelli, Saverio Caini, Giacomo Duroni, Ilaria Ermini, Elisa Pastore, Miriam Fontana, Luigi Facchini, Andrea Querci, Maria Antonietta Gilio, Vincenzo Mazzalupo, Melania Assedi, Daniela Ambrogetti, Domenico Palli
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer
Slavica Janeva, Ellen Krabbe, Toshima Z. Parris, Salmir Nasic, Marie Sundquist, Per Karlsson, Riccardo A. Audisio, Roger Olofsson Bagge, Anikó Kovács
Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer
Camille L. Duran, George S. Karagiannis, Xiaoming Chen, Ved P. Sharma, David Entenberg, John S. Condeelis, Maja H. Oktay
PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer
Fayun Zhang, Zifeng Zheng, Luoyang Wang, Wenfeng Zeng, Wenjing Wei, Chunling Zhang, Ziran Zhao, Wei Liang
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)
Judith M. Bliss, Holly Tovey, Abigail Evans, Chris Holcombe, Kieran Horgan, Elizabeth Mallon, Raghavan Vidya, Anthony Skene, Andrew Dodson, Margaret Hills, Simone Detre, Lila Zabaglo, Jane Banerji, Lucy Kilburn, James P. Morden, John F. R. Robertson, Ian Smith, Mitch Dowsett
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
Xi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, Gerrit-Jan Liefers, Badada Ananthamurthy Savitha, Payal Shrivastava, Chandra Prakash Vijay Kumar Serkad, Taranjot Kaur, Mallikarjuna Siraganahalli Eshwaraiah, Rob A. E. M. Tollenaar, Cornelis J. H. van de Velde, Caroline M. J. Seynaeve, Manjiri Bakre, Peter J. K. Kuppen
Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β
Yuko Murakami-Nishimagi, Kotaro Sugimoto, Makoto Kobayashi, Kazunoshin Tachibana, Manabu Kojima, Maiko Okano, Yuko Hashimoto, Shigehira Saji, Tohru Ohtake, Hideki Chiba
Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort
Charlotte Le Cornet, Audrey Y. Jung, Theron S. Johnson, Sabine Behrens, Nadia Obi, Heiko Becher, Jenny Chang-Claude, Renée T. Fortner
Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling
Heshu Liu, Rui Yan, Zeru Xiao, Xuying Huang, Jiannan Yao, Jian Liu, Guangyu An, Yang Ge
Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer
Chinnadurai Mani, Ganesh Acharya, Karunakar Saamarthy, Damieanus Ochola, Srinidhi Mereddy, Kevin Pruitt, Upender Manne, Komaraiah Palle
Modifiable risk factors in women at high risk of breast cancer: a systematic review
Sarah Y. Cohen, Carolyn R. Stoll, Akila Anandarajah, Michelle Doering, Graham A. Colditz
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, Maria Sofia Espejo, Tina M. Pedersen, Marco Mele, Helene L. Pedersen, Eva Balling, Tonje Johansen, Mark Burton, Mads Thomassen, Pernille Vahl, Peer Christiansen, Ebbe Boedtkjer
National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
Armin Aryannejad, Sahar Saeedi Moghaddam, Baharnaz Mashinchi, Mohammadreza Tabary, Negar Rezaei, Sarvenaz Shahin, Nazila Rezaei, Mohsen Abbasi-Kangevari, Zeinab Abbasi-Kangevari, Hedayat Abbastabar, Hassan Abidi, Hassan Abolhassani, Mohammad Aghaali, Bahman Ahadinezhad, Ali Ahmadi, Sepideh Ahmadi, Marjan Ajami, Mohammad Esmaeil Akbari, Yousef Alimohamadi, Sadaf Alipour, Vahid Alipour, Saeed Amini, Ali Arash Anoushirvani, Jalal Arabloo, Morteza Arab-Zozani, Bahar Ataeinia, Seyyed Shamsadin Athari, Abbas Azadmehr, Sina Azadnajafabad, Mohammadreza Azangou-Khyavy, Amirhossein Azari Jafari, Nader Bagheri, Sara Bagherieh, Saeed Bahadory, Sima Besharat, Somayeh Bohlouli, Natália Cruz-Martins, Mostafa Dianatinasab, Mojtaba Didehdar, Shirin Djalalinia, Fariba Dorostkar, Sharareh Eskandarieh, Bita Eslami, Shahab Falahi, Mohammad Farahmand, Ali Fatehizadeh, Masood Fereidoonnezhad, Nasrin Galehdar, Seyyed-Hadi Ghamari, Ahmad Ghashghaee, Maryam Gholamalizadeh, Ali Gholami, Pouya Goleij, Mohamad Golitaleb, Nima Hafezi-Nejad, Arvin Haj-Mirzaian, Aram Halimi, Soheil Hassanipour, Mohammad Heidari, Zahra Heidarymeybodi, Keyvan Heydari, Mohammad-Salar Hosseini, Elham Jamshidi, Roksana Janghorban, Ali Kabir, Leila R. Kalankesh, Taras Kavetskyy, Leila Keikavoosi-Arani, Mohammad Keykhaei, Rovshan Khalilov, Javad Khanali, Mahmoud Khodadost, Ali-Asghar Kolahi, Farzad Kompani, Hamid Reza Koohestani, Mozhgan Letafat-nezhad, Somayeh Livani, Amirhosein Maali, Farzan Madadizadeh, Soleiman Mahjoub, Ata Mahmoodpoor, Mohammad-Reza Malekpour, Reza Malekzadeh, Mohammad Ali Mansournia, Sahar Masoudi, Seyedeh Zahra Masoumi, Entezar Mehrabi Nasab, Seyyedmohammadsadeq Mirmoeeni, Esmaeil Mohammadi, Abdollah Mohammadian-Hafshejani, Mohammad Mohseni, Sara Momtazmanesh, Abdolvahab Moradi, Maryam Moradi, Yousef Moradi, Farhad Moradpour, Rahmatollah Moradzadeh, Abbas Mosapour, Mozhgan Moshtagh, Haleh MousaviIsfahani, Christopher J. L. Murray, Javad Nazari, Seyed Aria Nejadghaderi, Maryam Noori, Hassan Okati-Aliabad, Morteza Oladnabi, Babak Pakbin, Fatemeh PashazadehKan, Hamidreza Pazoki Toroudi, Naeimeh Pourtaheri, Navid Rabiee, Sima Rafiei, Fakher Rahim, Vahid Rahmanian, Samira Raoofi, Mahsa Rashidi, Mohammad-Mahdi Rashidi, Mohammad Sadegh Razeghinia, Nima Rezaei, Saeid Rezaei, Aziz Rezapour, Gholamreza Roshandel, Siamak Sabour, Maryam Sahebazzamani, Amirhossein Sahebkar, Soraya Sajadimajd, Sadaf G. Sepanlou, Saeed Shahabi, Fariba Shahraki-Sanavi, Javad Sharifi-Rad, Reza Shirkoohi, Parnian Shobeiri, Mohammad Sadegh Soltani-Zangbar, Elnaz Tabibian, Majid Taheri, Yasaman Taheri Abkenar, Ahmad Tavakoli, Amir Tiyuri, Seyed Abolfazl Tohidast, Sahel Valadan Tahbaz, Rohollah Valizadeh, Seyed Hossein YahyazadehJabbari, Leila Zaki, Maryam Zamanian, Iman Zare, Mohammad Zoladl, Mohsen Naghavi, Bagher Larijani, Farshad Farzadfar
TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects
Mohana Eswari Ragu, Joanna Mei Ch’wan Lim, Pei-Sze Ng, Cheng-Har Yip, Pathmanathan Rajadurai, Soo-Hwang Teo, Jia-Wern Pan
Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial
Jialing Zhang, Zongshi Qin, Tsz Him So, Tien Yee Chang, Sichang Yang, Haiyong Chen, Wing Fai Yeung, Ka Fai Chung, Pui Yan Chan, Yong Huang, Shifen Xu, Chun Yuan Chiang, Lixing Lao, Zhang-Jin Zhang
Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort
Cody Ramin, Lene H. S. Veiga, Jacqueline B. Vo, Rochelle E. Curtis, Clara Bodelon, Erin J. Aiello Bowles, Diana S. M. Buist, Sheila Weinmann, Heather Spencer Feigelson, Gretchen L. Gierach, Amy Berrington de Gonzalez
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors
Vera E. van der Noord, Wanda van der Stel, Gijs Louwerens, Danielle Verhoeven, Hendrik J. Kuiken, Cor Lieftink, Melanie Grandits, Gerhard F. Ecker, Roderick L. Beijersbergen, Peter Bouwman, Sylvia E. Le Dévédec, Bob van de Water
Vangl-dependent Wnt/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis
Kacey VanderVorst, Courtney A. Dreyer, Jason Hatakeyama, George R. R. Bell, Julie A. Learn, Anastasia L. Berg, Maria Hernandez, Hyun Lee, Sean R. Collins, Kermit L. Carraway III
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile
Marcel Smid, Marjanka K. Schmidt, Wendy J. C. Prager-van der Smissen, Kirsten Ruigrok-Ritstier, Maartje A. C. Schreurs, Sten Cornelissen, Aida Marsal Garcia, Annegien Broeks, A. Mieke Timmermans, Anita M. A. C. Trapman-Jansen, J. Margriet Collée, Muriel A. Adank, Maartje J. Hooning, John W. M. Martens, Antoinette Hollestelle
Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancer
Joseph R. Peterson, John A. Cole, John R. Pfeiffer, Gregory H. Norris, Yuhan Zhang, Dorys Lopez-Ramos, Tushar Pandey, Matthew Biancalana, Hope R. Esslinger, Anuja K. Antony, Vinita Takiar
S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
Mengxin Qi, Xianglan Yi, Baohui Yue, Mingxiang Huang, Sheng Zhou, Jing Xiong
Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy
Emily Hoffmann, Mirjam Gerwing, Tobias Krähling, Uwe Hansen, Katharina Kronenberg, Max Masthoff, Christiane Geyer, Carsten Höltke, Lydia Wachsmuth, Regina Schinner, Verena Hoerr, Walter Heindel, Uwe Karst, Michel Eisenblätter, Bastian Maus, Anne Helfen, Cornelius Faber, Moritz Wildgruber
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
Xiaojia Tang, Kevin J. Thompson, Krishna R. Kalari, Jason P. Sinnwell, Vera J. Suman, Peter T. Vedell, Sarah A. McLaughlin, Donald W. Northfelt, Alvaro Moreno Aspitia, Richard J. Gray, Jodi M. Carter, Richard Weinshilboum, Liewei Wang, Judy C. Boughey, Matthew P. Goetz
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations
Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. De La Vega, Yonglan Zheng, Toshio F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. Howard, Rita Nanda, Nike Beaubier, Kevin P. White, Dezheng Huo, Olufunmilayo I. Olopade
Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA
Jin Biao Xu, Jun Cao, Jin Xia, Ying Zhu, Yi He, Ming Guo Cao, Bing Mu Fang, Jean Paul Thiery, Wu Zhou
Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk, Robert D. Langer
Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study
Manlin Lang, Ping Liang, Huiming Shen, Hang Li, Ning Yang, Bo Chen, Yixu Chen, Hong Ding, Weiping Yang, Xiaohui Ji, Ping Zhou, ligang Cui, Jiandong Wang, Wentong Xu, Xiuqin Ye, Zhixing Liu, Yu Yang, Tianci Wei, Hui Wang, Yuanyuan Yan, Changjun Wu, Yiyun Wu, Jingwen Shi, Yaxi Wang, Xiuxia Fang, Ran li, Jie Yu
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
Shuying Liu, Shelly M. Xie, Wenbin Liu, Mihai Gagea, Ariella B. Hanker, Nguyen Nguyen, Akshara Singareeka Raghavendra, Gloria Yang-Kolodji, Fuliang Chu, Sattva S. Neelapu, Adriano Marchese, Samir Hanash, Johann Zimmermann, Carlos L. Arteaga, Debasish Tripathy
Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer
Chenxuan Yang, Jiaxiang Liu, Shuangtao Zhao, Qingyao Shang, Fei Ren, Kexin Feng, Ruixuan Zhang, Xiyu Kang, Xin Wang, Xiang Wang
Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach
Maya Illipse, Kamila Czene, Per Hall, Keith Humphreys
Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach
Giulia Ferroni, Soroosh Sabeti, Tasneem Abdus-Shakur, Lorenzo Scalise, Jodi M. Carter, Robert T. Fazzio, Nicholas B. Larson, Mostafa Fatemi, Azra Alizad
Influence of alcohol consumption and alcohol metabolism variants on breast cancer risk among Black women: results from the AMBER consortium
Kristin L. Young, Andrew F. Olshan, Kathryn Lunetta, Mariaelisa Graff, Lindsay A. Williams, Song Yao, Gary R. Zirpoli, Melissa Troester, Julie R. Palmer
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
Peter Schmid, Javier Cortes, Ana Joaquim, Noelia Martínez Jañez, Serafín Morales, Tamara Díaz-Redondo, Sibel Blau, Patrick Neven, Julie Lemieux, José Ángel García-Sáenz, Lowell Hart, Tsvetan Biyukov, Navid Baktash, Dan Massey, Howard A. Burris III, Hope S. Rugo
Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Kathleen A. O’Leary, Amber M. Bates, Won Jong Jin, Brian M. Burkel, Raghava N. Sriramaneni, Sarah E. Emma, Erin J. Nystuen, Elizabeth G. Sumiec, Suzanne M. Ponik, Zachary S. Morris, Linda A. Schuler
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
Lars v. B. Andersen, Martin J. Larsen, Helen Davies, Andrea Degasperi, Henriette Roed Nielsen, Louise A. Jensen, Lone Kroeldrup, Anne-Marie Gerdes, Anne-Vibeke Lænkholm, Torben A. Kruse, Serena Nik-Zainal, Mads Thomassen
Correction to: National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
Armin Aryannejad, Sahar Saeedi Moghaddam, Baharnaz Mashinchi, Mohammadreza Tabary, Negar Rezaei, Sarvenaz Shahin, Nazila Rezaei, Mohsen Naghavi, Bagher Larijani, Farshad Farzadfar, Mohsen Abbasi-Kangevari, Zeinab Abbasi-Kangevari, Hedayat Abbastabar, Hassan Abidi, Hassan Abolhassani, Mohammad Aghaali, Bahman Ahadinezhad, Ali Ahmadi, Sepideh Ahmadi, Marjan Ajami, Mohammad Esmaeil Akbari, Yousef Alimohamadi, Sadaf Alipour, Vahid Alipour, Saeed Amini, Ali Arash Anoushirvani, Jalal Arabloo, Morteza Arab-Zozani, Bahar Ataeinia, Seyyed Shamsadin Athari, Abbas Azadmehr, Sina Azadnajafabad, Mohammadreza Azangou-Khyavy, Amirhossein AzariJafari, Nader Bagheri, Sara Bagherieh, Saeed Bahadory, Sima Besharat, Somayeh Bohlouli, Natália Cruz-Martins, Mostafa Dianatinasab, Mojtaba Didehdar, Shirin Djalalinia, Fariba Dorostkar, Sharareh Eskandarieh, Bita Eslami, Shahab Falahi, Mohammad Farahmand, Ali Fatehizadeh, Masood Fereidoonnezhad, Nasrin Galehdar, Seyyed-Hadi Ghamari, Ahmad Ghashghaee, Maryam Gholamalizadeh, Ali Gholami, Pouya Goleij, Mohamad Golitaleb, Nima Hafezi-Nejad, Arvin Haj-Mirzaian, Aram Halimi, Soheil Hassanipour, Mohammad Heidari, Zahra Heidarymeybodi, Keyvan Heydari, Mohammad-Salar Hosseini, Elham Jamshidi, Roksana Janghorban, Ali Kabir, Leila R. Kalankesh, Taras Kavetskyy, Leila Keikavoosi-Arani, Mohammad Keykhaei, Rovshan Khalilov, Javad Khanali, Mahmoud Khodadost, Ali-Asghar Kolahi, Farzad Kompani, Hamid Reza Koohestani, Mozhgan Letafat-nezhad, Somayeh Livani, Amirhosein Maali, Farzan Madadizadeh, Soleiman Mahjoub, Ata Mahmoodpoor, Mohammad-Reza Malekpour, Reza Malekzadeh, Mohammad Ali Mansournia, Sahar Masoudi, Seyedeh Zahra Masoumi, Entezar MehrabiNasab, Seyyedmohammadsadeq Mirmoeeni, Esmaeil Mohammadi, Abdollah Mohammadian-Hafshejani, Mohammad Mohseni, Sara Momtazmanesh, Abdolvahab Moradi, Maryam Moradi, Yousef Moradi, Farhad Moradpour, Rahmatollah Moradzadeh, Abbas Mosapour, Mozhgan Moshtagh, Haleh MousaviIsfahani, Christopher J. L. Murray, Javad Nazari, Seyed Aria Nejadghaderi, Maryam Noori, Hassan Okati-Aliabad, Morteza Oladnabi, Babak Pakbin, Fatemeh PashazadehKan, Hamidreza PazokiToroudi, Naeimeh Pourtaheri, Navid Rabiee, Sima Rafiei, Fakher Rahim, Vahid Rahmanian, Samira Raoofi, Mahsa Rashidi, Mohammad-Mahdi Rashidi, Mohammad Sadegh Razeghinia, Nima Rezaei, Saeid Rezaei, Aziz Rezapour, Gholamreza Roshandel, Siamak Sabour, Maryam Sahebazzamani, Amirhossein Sahebkar, Soraya Sajadimajd, Sadaf G. Sepanlou, Saeed Shahabi, Fariba Shahraki-Sanavi, Javad Sharifi-Rad, Reza Shirkoohi, Parnian Shobeiri, Mohammad Sadegh Soltani-Zangbar, Elnaz Tabibian, Majid Taheri, Yasaman TaheriAbkenar, Ahmad Tavakoli, Amir Tiyuri, Seyed Abolfazl Tohidast, Sahel ValadanTahbaz, Rohollah Valizadeh, Seyed Hossein YahyazadehJabbari, Leila Zaki, Maryam Zamanian, Iman Zare, Mohammad Zoladl
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
Karin Kast, Esther M. John, John L. Hopper, Nadine Andrieu, Catherine Noguès, Emmanuelle Mouret-Fourme, Christine Lasset, Jean-Pierre Fricker, Pascaline Berthet, Véronique Mari, Lucie Salle, Marjanka K. Schmidt, Margreet G. E. M. Ausems, Encarnacion B. Gomez Garcia, Irma van de Beek, Marijke R. Wevers, D. Gareth Evans, Marc Tischkowitz, Fiona Lalloo, Jackie Cook, Louise Izatt, Vishakha Tripathi, Katie Snape, Hannah Musgrave, Saba Sharif, Jennie Murray, Sarah V. Colonna, Irene L. Andrulis, Mary B. Daly, Melissa C. Southey, Miguel de la Hoya, Ana Osorio, Lenka Foretova, Dita Berkova, Anne-Marie Gerdes, Edith Olah, Anna Jakubowska, Christian F. Singer, Yen Tan, Annelie Augustinsson, Johanna Rantala, Jacques Simard, Rita K. Schmutzler, Roger L. Milne, Kelly-Anne Phillips, Mary Beth Terry, David Goldgar, Flora E. van Leeuwen, Thea M. Mooij, Antonis C. Antoniou, Douglas F. Easton, Matti A. Rookus, Christoph Engel
RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling
Cornelia Tolg, Maja Milojevic, Freda W. Qi, Hailie A. Pavanel, M. Elizabeth O. Locke, Jenny Ma, Mathew Price, Andrew C. Nelson, James B. McCarthy, Kathleen A. Hill, Eva A. Turley
Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer
Yue Zhang, Lianqiu Lv, Renjing Zheng, Rong Xie, Yuanhang Yu, Han Liao, Jianying Chen, Bo Zhang
Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
Benita S. Katzenellenbogen, Valeria Sanabria Guillen, John A. Katzenellenbogen
Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy
Xinzhi Teng, Jiang Zhang, Xinyu Zhang, Xinyu Fan, Ta Zhou, Yu-hua Huang, Lu Wang, Elaine Yuen Phin Lee, Ruijie Yang, Jing Cai
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, Alexandra Mayer, Claudia Brito, Catarina Ramos, Catarina Bernardo, Mariane Cossito, Cláudia Furtado, Arlindo R. Ferreira, Diogo Martins-Branco, Ana da Costa Miranda, António Lourenço
MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study
Ah Young Park, Mi-Ryung Han, Bo Kyoung Seo, Hye-Yeon Ju, Gil Soo Son, Hye Yoon Lee, Young Woo Chang, Jungyoon Choi, Kyu Ran Cho, Sung Eun Song, Ok Hee Woo, Hyun Soo Park
Non-progressive breast carcinomas detected at mammography screening: a population study
Torunn Heggland, Lars Johan Vatten, Signe Opdahl, Harald Weedon-Fekjær
Preclinical and clinical activity of DZD1516, a full blood–brain barrier-penetrant, highly selective HER2 inhibitor
Jian Zhang, Nicholas P. McAndrew, Xiaojia Wang, Yiqun Du, Brian DiCarlo, Mei Wang, Kan Chen, Wenlei Yu, Xichun Hu
Exploring breast tissue microbial composition and the association with breast cancer risk factors
Rana German, Natascia Marino, Chris Hemmerich, Ram Podicheti, Douglas B. Rusch, Leah T. Stiemsma, Hongyu Gao, Xiaoling Xuei, Pam Rockey, Anna Maria Storniolo
Association of air pollution with postmenopausal breast cancer risk in UK Biobank
Carmen Smotherman, Brian Sprague, Susmita Datta, Dejana Braithwaite, Huaizhen Qin, Lusine Yaghjyan
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer
M. G. Muoio, M. Pellegrino, V. Rapicavoli, M. Talia, G. Scavo, V. Sergi, V. Vella, S. Pettinato, M. G. Galasso, R. Lappano, D. Scordamaglia, F. Cirillo, A. Pulvirenti, D. C. Rigiracciolo, M. Maggiolini, A. Belfiore, E. M. De Francesco
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
Wenjie Xia, Wuzhen Chen, Chao Ni, Xuli Meng, Jun Wu, Qiong Yang, Hongchao Tang, Hongjun Yuan, Shan Fang
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
Nisa Chuangchot, Pranisa Jamjuntra, Supaporn Yangngam, Piriya Luangwattananun, Suyanee Thongchot, Mutita Junking, Peti Thuwajit, Pa-Thai Yenchitsomanus, Chanitra Thuwajit
Deep learning applications to breast cancer detection by magnetic resonance imaging: a literature review
Richard Adam, Kevin Dell’Aquila, Laura Hodges, Takouhie Maldjian, Tim Q. Duong
Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
Chanjuan Zheng, Xi Xu, Muyao Wu, Lian Xue, Jianyu Zhu, Hongzhuo Xia, Siyu Ding, Shujun Fu, Xinyu Wang, Yian Wang, Guangchun He, Xia Liu, Xiyun Deng
The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case–control study
Annika Möhl, Sabine Behrens, Fabian Flaßkamp, Nadia Obi, Annika Kreienbrinck, Bernd Holleczek, Kathleen Gali, Jenny Chang-Claude, Heiko Becher
Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Huijuan Dai, Wenting Xu, Lulu Wang, Xiao Li, Xiaonan Sheng, Lei Zhu, Ye Li, Xinrui Dong, Weihang Zhou, Chenyu Han, Yan Mao, Linli Yao
miR-203 drives breast cancer cell differentiation
Nuria G. Martínez-Illescas, Silvia Leal, Patricia González, Osvaldo Graña-Castro, Juan José Muñoz-Oliveira, Alfonso Cortés-Peña, María Gómez-Gil, Zaira Vega, Verónica Neva, Andrea Romero, Miguel Quintela-Fandino, Eva Ciruelos, Consuelo Sanz, Sofía Aragón, Leisy Sotolongo, Sara Jiménez, Eduardo Caleiras, Francisca Mulero, Cristina Sánchez, Marcos Malumbres, María Salazar-Roa
Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women
Laurel A. Habel, Stacey E. Alexeeff, Ninah Achacoso, Vignesh A. Arasu, Aimilia Gastounioti, Lawrence Gerstley, Robert J. Klein, Rhea Y. Liang, Jafi A. Lipson, Walter Mankowski, Laurie R. Margolies, Joseph H. Rothstein, Daniel L. Rubin, Li Shen, Adriana Sistig, Xiaoyu Song, Marvella A. Villaseñor, Mark Westley, Alice S. Whittemore, Martin J. Yaffe, Pei Wang, Despina Kontos, Weiva Sieh
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Pooja Middha, Xiaoliang Wang, Sabine Behrens, Manjeet K. Bolla, Qin Wang, Joe Dennis, Kyriaki Michailidou, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Paul L. Auer, Annelie Augustinsson, Thaïs Baert, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Javier Benitez, Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Angela Brooks-Wilson, Daniele Campa, Federico Canzian, Angel Carracedo, Jose E. Castelao, Stephen J. Chanock, Georgia Chenevix-Trench, Emilie Cordina-Duverger, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Laure Dossus, Pierre-Antoine Dugué, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Olivia Fletcher, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Graham G. Giles, Anna González-Neira, Felix Grassmann, Anne Grundy, Pascal Guénel, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Susan E. Hankinson, Elaine F. Harkness, Bernd Holleczek, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, David J. Hunter, Christian Ingvar, Karolin Isaksson, Helena Jernström, Esther M. John, Michael E. Jones, Rudolf Kaaks, Renske Keeman, Cari M. Kitahara, Yon-Dschun Ko, Stella Koutros, Allison W. Kurian, James V. Lacey, Diether Lambrechts, Nicole L. Larson, Susanna Larsson, Loic Le Marchand, Flavio Lejbkowicz, Shuai Li, Martha Linet, Jolanta Lissowska, Maria Elena Martinez, Tabea Maurer, Anna Marie Mulligan, Claire Mulot, Rachel A. Murphy, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Aaron Norman, Katie M. O’Brien, Janet E. Olson, Alpa V. Patel, Ross Prentice, Erika Rees-Punia, Gad Rennert, Valerie Rhenius, Kathryn J. Ruddy, Dale P. Sandler, Christopher G. Scott, Mitul Shah, Xiao-Ou Shu, Ann Smeets, Melissa C. Southey, Jennifer Stone, Rulla M. Tamimi, Jack A. Taylor, Lauren R. Teras, Katarzyna Tomczyk, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Sophia S. Wang, Clarice R. Weinberg, Hans Wildiers, Walter Willett, Stacey J. Winham, Alicja Wolk, Xiaohong R. Yang, M. Pilar Zamora, Wei Zheng, Argyrios Ziogas, Alison M. Dunning, Paul D. P. Pharoah, Montserrat García-Closas, Marjanka K. Schmidt, Peter Kraft, Roger L. Milne, Sara Lindström, Douglas F. Easton, Jenny Chang-Claude
Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer
M. G. Muoio, M. Pellegrino, V. Rapicavoli, M. Talia, G. Scavo, V. Sergi, V. Vella, S. Pettinato, M. G. Galasso, R. Lappano, D. Scordamaglia, F. Cirillo, A. Pulvirenti, D. C. Rigiracciolo, M. Maggiolini, A. Belfiore, E. M. De Francesco
Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case–control study of the Multiethnic Cohort Study
Mindy C. DeRouen, Juan Yang, Yuqing Li, Adrian A. Franke, Anne N. Tome, Kami K. White, Brenda Y. Hernandez, Yurii Shvetsov, Veronica Setiawan, Anna H. Wu, Lynne R. Wilkens, Loïc Le Marchand, Lenora W. M. Loo, Iona Cheng
SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models
Feng Zhou, Guimei Yang, Liting Xue, Yajing Liu, Yao Guo, Ji Zhu, Linlin Yuan, Peng Gu, Feng Tang, Jinwen Shan, Renhong Tang
Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast
Mustapha Abubakar, Alyssa Klein, Shaoqi Fan, Scott Lawrence, Karun Mutreja, Jill E. Henry, Ruth M. Pfeiffer, Maire A. Duggan, Gretchen L. Gierach
Correction: Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1
Shuiyi Liu, Weiqun Chen, Hui Hu, Tianzhu Zhang, Tangwei Wu, Xiaoyi Li, Yong Li, Qinzhi Kong, Hongda Lu, Zhongxin Lu
FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer
Marisol Castillo-Castrejon, Barbara Mensah Sankofi, Stevi Johnson Murguia, Abasi-ama Udeme, Hoaning Howard Cen, Yi Han Xia, Nisha S. Thomas, William L. Berry, Kenneth L. Jones, Vincent R. Richard, Rene P. Zahedi, Christoph H. Borchers, James D. Johnson, Elizabeth A. Wellberg
Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors
Wei Yang, Meiyu Xu, Shuoqi Xu, Qingxian Guan, Shuaiming Geng, Juanhong Wang, Wei Wei, Hongwei Xu, Ying Liu, Yong Meng, Ming-Qing Gao
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
L. Lukas Löfling, Nathalie C. Støer, Bettina Kulle Andreassen, Giske Ursin, Edoardo Botteri
Phenotypically sorted highly and weakly migratory triple negative breast cancer cells exhibit migratory and metastatic commensalism
Lauren A. Hapach, Wenjun Wang, Samantha C. Schwager, Devika Pokhriyal, Emily D. Fabiano, Cynthia A. Reinhart-King
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
P. Neven, P. A. Fasching, S. Chia, G. Jerusalem, M. De Laurentiis, S.-A. Im, K. Petrakova, G. V. Bianchi, M. Martín, A. Nusch, G. S. Sonke, L. De la Cruz-Merino, J. T. Beck, J. P. Zarate, Y. Wang, A. Chakravartty, C. Wang, D. J. Slamon
The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer
Rhianna Rachael Romany Blyth, Charles N. Birts, Stephen A. Beers
Receptor conversion and survival in breast cancer liver metastases
Marcus Sundén, Sofia Norgren, Robert Lundqvist, Anne Andersson, Malin Sund, Oskar Hemmingsson
Evaluation of the association of area-level socioeconomic deprivation and breast cancer recurrence by oestrogen receptor subtypes in Scotland
Hayley M. Dunlop, Linda J. Williams, Peter S. Hall, Matthew Barber, Christine Dodds, Jonine D. Figueroa
Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
Rifat Jan, Min Huang, Joan Lewis-Wambi
Re: Non-progressive breast carcinomas detected at mammography screening: a population study—a model test or a novel test of cancer regression?
Per-Henrik Zahl
Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
Dan Luo, Yiran Liang, Yajie Wang, Fangzhou Ye, Yuhan Jin, Yaming Li, Dianwen Han, Zekun Wang, Bing Chen, Wenjing Zhao, Lijuan Wang, Xi Chen, Liyu Jiang, Qifeng Yang
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Christine Lundgren, Julia Tutzauer, Sarah E. Church, Olle Stål, Maria Ekholm, Carina Forsare, Bo Nordenskjöld, Mårten Fernö, Pär-Ola Bendahl, Lisa Rydén
Native American ancestry and breast cancer risk in Colombian and Mexican women: ruling out potential confounding through ancestry-informative markers
Linda Zollner, Diana Torres, Ignacio Briceno, Michael Gilbert, Gabriela Torres-Mejía, Joe Dennis, Manjeet K. Bolla, Qin Wang, Ute Hamann, Justo Lorenzo Bermejo
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah, Charles S. Dai, Carolina Reduzzi, Paolo D’Amico, Firas Wehbe, Arielle Medford, Seth A. Wander, William J. Gradishar, Amir Behdad, Fabio Puglisi, Cynthia X. Ma, Aditya Bardia, Massimo Cristofanilli
Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now
Xiaowei Qi, Qiyun Shi, Juncheng Xuhong, Yi Zhang, Jun Jiang
Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs
Joshua Watson, Tianfang Wang, Kun-Lin Ho, Yuan Feng, Tanakamol Mahawan, Kevin K. Dobbin, Shaying Zhao
The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition
Linlin Zhou, Jichun Wu, Mei Ruan, Yonglei Xiao, Hailin Lan, Qiongwen Wu, Chen-Wei Yu, Qiuyu Zhang
Impact of breast density on diagnostic accuracy in digital breast tomosynthesis versus digital mammography: results from a European screening trial
Jakob Olinder, Kristin Johnson, Anna Åkesson, Daniel Förnvik, Sophia Zackrisson
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer
Tessa G. Steenbruggen, Denise M. Wolf, Michael J. Campbell, Joyce Sanders, Sten Cornelissen, Bram Thijssen, Roberto A. Salgado, Christina Yau, Nick O-Grady, Amrita Basu, Rajith Bhaskaran, Lorenza Mittempergher, Gillian L. Hirst, Jean-Philippe Coppe, Marleen Kok, Gabe S. Sonke, Laura J. van ‘t Veer, Hugo M. Horlings
Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland
Bradley A. Krisanits, Reid Schuster, Jaime Randise, Lourdes M. Nogueira, Jackson T. Lane, Gowtami A. Panguluri, Hong Li, Kristi Helke, Maria C. Cuitiño, Christopher Koivisto, Laura Spruill, Michael C. Ostrowski, Steven M. Anderson, David P. Turner, Victoria J. Findlay
MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib
Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Barbara Pasculli, Alexander Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler
Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity
Carson D. Broeker, Mylena M. O. Ortiz, Michael S. Murillo, Eran R. Andrechek
Lipidome of mammographic breast density in premenopausal women
Kayla R. Getz, Myung Sik Jeon, Chongliang Luo, Jingqin Luo, Adetunji T. Toriola
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
Gudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, Johan Hartman, Ana Bosch, Johan Staaf, Fredrika Killander, Emma Niméus
Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR
Cuiwei Liu, Chong Lu, Lamu Yixi, Jiaxing Hong, Fang Dong, Shengnan Ruan, Ting Hu, Xiangwang Zhao
Circulating neutrophils from patients with early breast cancer have distinct subtype-dependent phenotypes
Anisha Ramessur, Bana Ambasager, Iker Valle Aramburu, Freddie Peakman, Kelly Gleason, Christoph Lehmann, Venizelos Papayannopoulos, Raoul Charles Coombes, Ilaria Malanchi
Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer
Shikun Zhu, Mi Zhang, Xuexue Liu, Qing Luo, Jiahong Zhou, Miao Song, Jia Feng, Jinbo Liu
Causal relationships between breast cancer risk factors based on mammographic features
Zhoufeng Ye, Tuong L. Nguyen, Gillian S. Dite, Robert J. MacInnis, Daniel F. Schmidt, Enes Makalic, Osamah M. Al-Qershi, Minh Bui, Vivienne F. C. Esser, James G. Dowty, Ho N. Trinh, Christopher F. Evans, Maxine Tan, Joohon Sung, Mark A. Jenkins, Graham G. Giles, Melissa C. Southey, John L. Hopper, Shuai Li
The inhibitory effect of Gremlin-2 on adipogenesis suppresses breast cancer cell growth and metastasis
Jiwoo Jung, Na Hui Kim, Minji Kwon, Jayeon Park, Dayeon Lim, Youjin Kim, World Gil, Ye Hwang Cheong, Sin-Aye Park
The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
Huibian Zhang, Min Gao, Wenying Zhao, Lin Yu
Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer
Marit Busund, Giske Ursin, Eiliv Lund, Tom Wilsgaard, Charlotta Rylander
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Hakim Bouamar, Larry Esteban Broome, Kate Ida Lathrop, Ismail Jatoi, Andrew Jacob Brenner, Alia Nazarullah, Karla Moncada Gorena, Michael Garcia, Yidong Chen, Virginia Kaklamani, Lu-Zhe Sun
Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
Yunfang Yu, Wei Ren, Zifan He, Yongjian Chen, Yujie Tan, Luhui Mao, Wenhao Ouyang, Nian Lu, Jie Ouyang, Kai Chen, Chenchen Li, Rong Zhang, Zhuo Wu, Fengxi Su, Zehua Wang, Qiugen Hu, Chuanmiao Xie, Herui Yao
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
María C. Díaz Flaqué, Natalia M. Galigniana, Wendy Béguelin, Rocío Vicario, Cecilia J. Proietti, Rosalía Cordo Russo, Martín A. Rivas, Mercedes Tkach, Pablo Guzmán, Juan C. Roa, Esteban Maronna, Viviana Pineda, Sergio Muñoz, María Florencia Mercogliano, Eduardo H. Charreau, Patricio Yankilevich, Roxana Schillaci, Patricia V. Elizalde
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
Ji Eun Choi, Jae Seok Lee, Min-Sun Jin, Ilias P. Nikas, Kwangsoo Kim, Sunah Yang, Soo Young Park, Jiwon Koh, Sohyeon Yang, Seock-Ah Im, Han Suk Ryu
Exploring the interface zone in breast cancer: implications for surgical strategies and beyond
Kefah Mokbel, Munaser Alamoodi
Alterations to DNA methylation patterns induced by chemotherapy treatment are associated with negative impacts on the olfactory pathway
Peh Joo Ho, Alexis Jiaying Khng, Benita Kiat-Tee Tan, Geok Hoon Lim, Su-Ming Tan, Veronique Kiak Mien Tan, Ryan Shea Ying Cong Tan, Elaine Hsuen Lim, Philip Tsau-Choong Iau, Ying Jia Chew, Yi Ying Lim, Mikael Hartman, Ern Yu Tan, Jingmei Li
A catchment and location-allocation analysis of mammography access in Delaware, US: implications for disparities in geographic access to breast cancer screening
Jessica L. Webster, Neal D. Goldstein, Jennifer P. Rowland, Catherine M. Tuite, Scott D. Siegel
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer
Anum S. Kazerouni, Lanell M. Peterson, Isaac Jenkins, Alena Novakova-Jiresova, Hannah M. Linden, Julie R. Gralow, David M. Hockenbery, David A. Mankoff, Peggy L. Porter, Savannah C. Partridge, Jennifer M. Specht
High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients
Kåre Nielsen, Michael Sode, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm
Blocking channels to metastasis: targeting sodium transport in breast cancer
William J. Brackenbury, Carlo Palmieri
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer
Mario Campone, François-Clément Bidard, Patrick Neven, Lei Wang, Bin Ling, Yvonne Dong, Gautier Paux, Christina Herold, Ugo De Giorgi
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning
Witali Aswolinskiy, Enrico Munari, Hugo M. Horlings, Lennart Mulder, Giuseppe Bogina, Joyce Sanders, Yat-Hee Liu, Alexandra W. van den Belt-Dusebout, Leslie Tessier, Maschenka Balkenhol, Michelle Stegeman, Jeffrey Hoven, Jelle Wesseling, Jeroen van der Laak, Esther H. Lips, Francesco Ciompi
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin
Héctor Franco-Valls, Elsa Tusquets-Uxó, Laura Sala, Maria Val, Raúl Peña, Alessandra Iaconcig, Álvaro Villarino, Martín Jiménez-Arriola, Pere Massó, Juan L. Trincado, Eduardo Eyras, Andrés F. Muro, Jorge Otero, Antonio García de Herreros, Josep Baulida
The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling
Deeksha Sharma, Cody G. Hager, Li Shang, Lam Tran, Yongyou Zhu, Aihui Ma, Brian Magnuson, Matthew W. Lesko, Max S. Wicha, Monika L. Burness
Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer
Noortje Verschoor, Marcel Smid, Agnes Jager, Stefan Sleijfer, Saskia M. Wilting, John W. M. Martens
Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer
Menekse Göker, Hannelore Denys, An Hendrix, Olivier De Wever, Koen Van de Vijver, Geert Braems
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study
Emma C. Atakpa, Diana S. M. Buist, Erin J. Aiello Bowles, Jack Cuzick, Adam R. Brentnall
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
Zheqiong Tan, Pragney Deme, Keerti Boyapati, Britt S. R. Claes, Annet A. M. Duivenvoorden, Ron M. A. Heeren, Caitlin M. Tressler, Norman James Haughey, Kristine Glunde
Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study
Shih-Kai Hung, Hsuan-Ju Yang, Moon-Sing Lee, Dai-Wei Liu, Liang-Cheng Chen, Chia-Hui Chew, Chun-Hung Lin, Cheng-Hung Lee, Szu-Chin Li, Chung-Lin Hong, Chih-Chia Yu, Ben-Hui Yu, Feng-Chun Hsu, Wen-Yen Chiou, Hon-Yi Lin
Mosquito control exposures and breast cancer risk: analysis of 1071 cases and 2096 controls from the Ghana Breast Health Study
Naomie Olivos, Jim E. Banta, Rhonda Spencer-Hwang, Daniel Ansong, Laura E. Beane Freeman, Joe-Nat Clegg-Lamptey, Beatrice Wiafe-Addai, Lawrence Edusei, Ernest Adjei, Nicholas Titiloye, Florence Dedey, Francis Aitpillah, Joseph Oppong, Verna Vanderpuye, Ernest Osei-Bonsu, Thomas U. Ahearn, Richard Biritwum, Joel Yarney, Baffour Awuah, Kofi Nyarko, Montserrat Garcia-Closas, Mustapha Abubakar, Louise A. Brinton, Jonine D. Figueroa, Seth Wiafe
Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA
Pan Hu, Peiyi Zhou, Tieyun Sun, Dingkang Liu, Jun Yin, Lubin Liu
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I. Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Huang
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W. P. Friedl
HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
Jeongmin Seo, Jiwon Koh, Dae-Won Lee, Jinyong Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im
Association between allostatic load and breast cancer risk: a cohort study
Yufan Guan, Jie Shen, Juan Lu, Bernard F. Fuemmeler, Lisa S. Shock, Hua Zhao